Shanshui Technology (301190.SZ) released its semi-annual report for 2024, with revenue of 0.248 billion yuan, a year-on-year increase of 4.91%. The net income attributable to shareholders of the listed company decreased by 24.87% to 54.1487 million yuan. The net income attributable to shareholders of the listed company, after deducting non-recurring gains and losses, decreased by 14.39% to 54.0058 million yuan. The basic earnings per share is 0.2571 yuan.

The announcement shows that the construction of the chloropyridine production line, a funded investment project of the company, is progressing smoothly, and some units have entered the trial production stage. The company actively adjusts its overall business plan to ensure the project can start trial production as soon as possible. It has seconded some personnel from ZHongli Chemical's chloropyridine production line to the funded investment project in order to integrate various resources and achieve economies of scale.